A 71-year-old woman presented to the clinic for biannual carotid duplex ultrasonography. Her medical history included cerebrovascular disease, congestive heart failure, chronic obstructive pulmonary disease, hypertension, and skin infections resulting from methicillin-resistant 
Report of Case

Discussion
With patch closure being the standard of care for patients with CEA, consideration must be given to the type of patch that will be used. Although the preference of the surgeon has an obvious role in this decision, other properties should also be considered to ensure adequate longterm results. The biologic properties of ECM and its potential inherent mechanical and biologic advantages over other types of patches should be understood.
Small intestine submucosa (SIS) has been the most extensively studied ECM patch material. 9 The composi- 
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biologic properties of the ECM patch make the use of this material a valid alternative. 16 As seen in our patient's surgical history, restenosis is a major challenge when considering the long-term outcome of CEA. Several studies assessing restenosis in patients who have undergone peripheral bypasses have demonstrated that mechanical factors, including material mismatch and compliance mismatch, are associated with decreased short-and long-term patencies. 17 Moreover, the lack of a confluent endothelium associated with synthetic materials is also involved in thrombus formation, embolism, and occlusion. 12 Comparison of various bypass materials has demonstrated that the physical properties of SIS more closely resemble those of the native arteries than vein or synthetic grafts, thereby minimizing these discrepancies. 18 Although no similar studies to our 
Conclusion
The ideal carotid patch material has yet to be identified.
Perioperative complications, ease of handling, economic factors, and long-term outcomes must all be taken into account when assessing such materials. We believe that an ECM patch may offer an attractive alternative to tration of SIS includes approximately 90% collagen (primarily type I collagen). In addition, SIS ECM also contains glycosaminoglycans, including heparin and heparin sulfate, 10 as well as fibronectin and laminin, which are sources of growth factors. 11 The CorMatrix ECM used in our patient is an example of an acellular porcine SIS non-cross-linked ECM material.
Physiologic remodeling is associated with different types of carotid patches. When a synthetic patch material is inserted, an inflammatory cascade is initiated that leads to the release of proinflammatory cytokines, ultimately resulting in inflammation and fibrosis. 12 The end result of these processes is evident in any repeated surgical procedure, as seen with our patient. In contrast, when ECM patch materials are inserted, the process of macrophage infiltration initiates an anti-inflammatory cascade characterized by secretion of regenerative factors that promote cell proliferation and angiogenesis and enhance the rate of endothelization, 13 yielding a more physiologic-based remodeling process.
As a possible complication of CEA, infection is associated with potentially fatal sequelae that have an estimated incidence of less than 1%. 14 
